ADMA Biologics's total assets for Q4 2025 were $624.24M, an increase of 9.77% from the previous quarter. ADMA total liabilities were $146.92M for the fiscal quarter, a 6.85% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.